09/30/2026
Does Ozempic protect your brain? 🧠 👉Here's what the newest research shows:
❌ As a treatment: the largest trial ever (EVOKE, ~3,800 people with early Alzheimer's) found semaglutide did not slow memory loss over 2 years. It did lower a tau marker by about 10%, but not enough to help patients.
🟣 For prevention: observational studies in adults with type 2 diabetes show a 29–36% lower incidence of dementia among GLP-1 users. These are associations, not causation, and residual confounding (e.g., healthier-user bias) cannot be excluded. Randomized prevention data are needed. The Alzheimer's Association's PROTECT-Cog trial (~$100M) is now designed to answer that question.
🧠 Dr. Tasha Powell's opinion: "I'm a big believer that GLP-1s will prove to be potent protectors against neuroinflammation and will help lower the risk of dementia onset. The EVOKE trial started GLP-1s too late, after patients were already symptomatic. Once the disease process is underway, it's much harder to show a benefit."
✅ Proven today: GLP-1s lower stroke risk by about 16%, and tirzepatide is FDA-approved for sleep apnea. Both are big drivers of brain aging.
⚠️ The trade-off: some of the weight lost can be muscle. If you're on a GLP-1, strength train, prioritize protein, and practice balance daily.
Dr. Powell's 3 rules for patients:
1️⃣ Don't start a GLP-1 to treat memory loss, but it likely benefits prevention of memory decline if started before dementia symptoms.
2️⃣ Do treat your metabolic health. That IS brain care.
3️⃣ The drug isn't the foundation. Exercise, sleep, connection, and learning new skills come first.
Metabolic health is brain health. 💜
📌 Save this for your next checkup
📤 Send it to someone on a GLP-1
💬 Questions? Drop them below
Educational content only, not medical advice. Talk with your doctor before starting or stopping any medication.